Wanbury successfully completes USFDA inspection at its API facility in Tanuku

03 Aug 2016 Evaluate

Wanbury has successful completed US Food and Drug Administration (USFDA) inspection at its major API facility in Tanuku with one observation. The same was addressed and resolved by the Regulatory Team in time. The audit was carried out for a period of 5 days and concluded successfully.

Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. The company’s major thrust area lies in Active Pharmaceutical Ingredient (API) sale in over 70 countries and Pan-India Formulation presence.

Wanbury Share Price

230.60 3.45 (1.52%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×